fda warning bpc-157 unapproved drug 2024 Approval Status: Is It Approved for Human Use? FDA's Overreach on Compounded Peptides

The adverse reactions observed with ZEPBOUND 10 mg or 15 mg administered subcutaneously once weekly were similar to those reported in the two pooled placebo controlled clinical trials for weight reduction (Study 1 and Study 2)

One of the most compelling aspects of knee gel injections is their potential to delay or even eliminate the need for knee replacement surgery

10.1210/jcem.87.6.8567 209 MountM

Instead, it is being studied for its potential effects on energy expenditure, fat metabolism, and metabolic regulation

State medical boards, health departments, and clinical accreditation bodies (CQC in the UK) expect documented informed consent before parenteral therapies